FR2305177B1 - - Google Patents

Info

Publication number
FR2305177B1
FR2305177B1 FR7608916A FR7608916A FR2305177B1 FR 2305177 B1 FR2305177 B1 FR 2305177B1 FR 7608916 A FR7608916 A FR 7608916A FR 7608916 A FR7608916 A FR 7608916A FR 2305177 B1 FR2305177 B1 FR 2305177B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7608916A
Other languages
French (fr)
Other versions
FR2305177A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2305177A1 publication Critical patent/FR2305177A1/fr
Application granted granted Critical
Publication of FR2305177B1 publication Critical patent/FR2305177B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7608916A 1975-03-27 1976-03-26 Compositions a base de prostaglandines Granted FR2305177A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/562,535 US3966962A (en) 1975-03-27 1975-03-27 Triacetin solutions of PGE-type compounds

Publications (2)

Publication Number Publication Date
FR2305177A1 FR2305177A1 (fr) 1976-10-22
FR2305177B1 true FR2305177B1 (US20110009641A1-20110113-C00185.png) 1982-10-08

Family

ID=24246672

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7608916A Granted FR2305177A1 (fr) 1975-03-27 1976-03-26 Compositions a base de prostaglandines

Country Status (11)

Country Link
US (1) US3966962A (US20110009641A1-20110113-C00185.png)
JP (1) JPS6020365B2 (US20110009641A1-20110113-C00185.png)
BE (1) BE840075A (US20110009641A1-20110113-C00185.png)
CA (1) CA1044140A (US20110009641A1-20110113-C00185.png)
DE (1) DE2611183C2 (US20110009641A1-20110113-C00185.png)
FR (1) FR2305177A1 (US20110009641A1-20110113-C00185.png)
GB (1) GB1493092A (US20110009641A1-20110113-C00185.png)
HK (1) HK10481A (US20110009641A1-20110113-C00185.png)
MX (1) MX3794E (US20110009641A1-20110113-C00185.png)
NL (1) NL190539C (US20110009641A1-20110113-C00185.png)
ZA (1) ZA761306B (US20110009641A1-20110113-C00185.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU510190B2 (en) * 1976-08-14 1980-06-12 Carlson, Lars A Prostaglandin method
DE2740953A1 (de) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
US4301175A (en) * 1980-12-29 1981-11-17 The Upjohn Company E-Type prostaglandin compositions
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
CA1216793A (en) * 1982-07-19 1987-01-20 Cheng-Der Yu Pge-type compositions encapsulated by acid isolated gelatin
US4431833A (en) * 1982-12-27 1984-02-14 American Cyanamid Company Prostaglandin and hydroxylated fatty acid ester formulations
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures
US4955878A (en) * 1986-04-04 1990-09-11 Biotechnology, Inc. Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
AU5018693A (en) * 1992-09-21 1994-04-12 Upjohn Company, The Sustained-release protein formulations
ATE402925T2 (de) 1999-10-15 2008-08-15 Sucampo Ag Neue zusammensetzung enthaltend eine bicyclische verbindung und ein glycerid
US20100286101A1 (en) * 2009-05-07 2010-11-11 Jason Carbol Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability
WO2015200444A1 (en) * 2014-06-24 2015-12-30 Saudi Arabian Oil Company Encapsulation of an acid precursor for oil field applications
US20230338322A1 (en) * 2020-05-04 2023-10-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Glyceryltriacetate (gta) for use in improving breathing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA721937B (en) * 1971-10-22 1972-12-27 Upjohn Co Pharmaceutical preparations and uses thereof
US3829579A (en) * 1971-11-01 1974-08-13 Upjohn Co Stable solutions of pge-type compounds
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same
JPS5729463B2 (US20110009641A1-20110113-C00185.png) * 1973-12-07 1982-06-23

Also Published As

Publication number Publication date
NL7603064A (nl) 1976-09-29
CA1044140A (en) 1978-12-12
JPS6020365B2 (ja) 1985-05-21
ZA761306B (en) 1977-02-23
US3966962A (en) 1976-06-29
JPS51112508A (en) 1976-10-05
NL190539B (nl) 1993-11-16
HK10481A (en) 1981-03-27
DE2611183A1 (de) 1976-10-14
MX3794E (es) 1981-07-22
GB1493092A (en) 1977-11-23
FR2305177A1 (fr) 1976-10-22
DE2611183C2 (de) 1985-08-14
NL190539C (nl) 1994-04-18
AU1194876A (en) 1977-09-15
BE840075A (fr) 1976-09-27

Similar Documents

Publication Publication Date Title
FR2305177B1 (US20110009641A1-20110113-C00185.png)
JPS5192267A (US20110009641A1-20110113-C00185.png)
JPS5621226B2 (US20110009641A1-20110113-C00185.png)
JPS5289817U (US20110009641A1-20110113-C00185.png)
JPS5284732U (US20110009641A1-20110113-C00185.png)
JPS5328106Y2 (US20110009641A1-20110113-C00185.png)
JPS5254146Y2 (US20110009641A1-20110113-C00185.png)
JPS5291627U (US20110009641A1-20110113-C00185.png)
JPS5286092U (US20110009641A1-20110113-C00185.png)
JPS5238221U (US20110009641A1-20110113-C00185.png)
JPS5224559U (US20110009641A1-20110113-C00185.png)
JPS51125419U (US20110009641A1-20110113-C00185.png)
CH601775A5 (US20110009641A1-20110113-C00185.png)
CH599921A5 (US20110009641A1-20110113-C00185.png)
CH604784A5 (US20110009641A1-20110113-C00185.png)
CH603868A5 (US20110009641A1-20110113-C00185.png)
CH603846A5 (US20110009641A1-20110113-C00185.png)
CH603712A5 (US20110009641A1-20110113-C00185.png)
BG21320A1 (US20110009641A1-20110113-C00185.png)
BG21746A1 (US20110009641A1-20110113-C00185.png)
BG22049A1 (US20110009641A1-20110113-C00185.png)
BG22247A1 (US20110009641A1-20110113-C00185.png)
CH602889A5 (US20110009641A1-20110113-C00185.png)
CH602136A5 (US20110009641A1-20110113-C00185.png)
CH605003A5 (US20110009641A1-20110113-C00185.png)